FDA Approved: MYTESI — Supplemental Application (Napo Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Mytesi (crofelemer) submitted by Napo Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Mytesi (crofelemer)

Snippet

SUPPL AP for MYTESI (CROFELEMER)